A

Arvinas

D

ARVN

USD

0.63

(2.522%)

Market Closed

18,694.00

حجم التداول

-4.1

الربح لكل سهم

-

العائد الربحي

-4.832075

P/E

1,758,076,842.21

حجم السوق

اليوم

2.5220%

1 اسبوع

4.488%

1 شهر

0.589%

6 اشهر

-39.784%

12 اشهر

4.488%

بداية السنة

-37.840%

كل الوقت

0%

أصول ذات صلة

Title:
Arvinas

Sector:

Healthcare

Industry:

Biotechnology

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا